APS
2023 APS Annual Convention · 2023
Study Design of Schemodep: Effectivity and Working Mechanisms of Schema Therapy for Patients with Treatment Resistant Depression
- Bob Baxendell
Radboud University - Bob Baxendell
Pro Persona - Jan Spijker
Pro Persona Mental Health Care - Jan Spijker
Radboud University - Indira Tendolkar
Donders Institute for Brain, Cognition and Behaviour - Indira Tendolkar
Radboud University Medical Center - Ger Keijsers
Maastricht University - Ger Keijsers
Radboud University - Ger Keijsers
Pro Persona - Janna Vrijsen
Pro Persona Mental Health Care - Janna Vrijsen
Radboud University Medical Center
Abstract
Despite the increased popularity of Schema Therapy (ST) as treatment of patients with a Treatment Resistant Depression (TRD), relatively little empirical evidence if available. The current study uses a multiple baseline design to study the effectivity and working mechanisms of ST within patients with a TRD.
